Antifibrotics in glaucoma surgery: current practices and future directions
While MMC remains the gold standard antifibrotic agent for glaucoma surgery, there are numerous antifibrotic agents in development with safer side effect profiles and similar success rates that may change the surgical practice of glaucoma.
Authors
- Christopher Santilli (ORCID: https://orcid.org/0000-0002-9250-7137)
- Huda Sheheitli
Institutions
- University of Minnesota (US)
- Midwest Orthopaedic Research Foundation (US)
Publication Details
- Journal
- Current Opinion in Ophthalmology
- Published
- 2025-11-27
- DOI
- https://doi.org/10.1097/icu.0000000000001195
- Primary Topic
- Glaucoma and retinal disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00